Please login to the form below
Digital intelligence blog
Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools
Going digital
Unlocking the potential of science and technology in the UK23 Jan 2019
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader
D-day: time to make digital deliver18 Dec 2018
Chris Ross looks at why a platform-based, outcomes-focused approach could be key to demonstrating the value of digital health solutions
eConsent: Busting regulatory myths10 Dec 2018
‘eConsent improves the way consent is obtained, helps keep participants better informed and easily tracks study progress results’
Entering the era of digital trials14 Nov 2018
How technology is transforming the design, conduct and analysis of clinical research
Digital Trials31 Oct 2018
A framework for success
Safety first: AI adoption in the healthcare sector24 Oct 2018
AI's transformative impact on healthcare
Artificial intelligence in healthcare22 Oct 2018
What are the benefits for pharma?
Pharma social media12 Oct 2018
Posting frequency is down as companies take a ‘less is more’ approach
Novartis launch NET cancer community app17 Jul 2018
Galaxies of Hope aims to provide support to cancer patients
Share
Featured jobs
- Client Partner, Healthcare Brand Communications, London
-
Highly competitive package
- Publications Director, Medical Communications agency, Cambridge
-
Competitive Salary
- Publications Director, Medical Communications agency, Home Based...
-
Competitive Salary
- Publications Director, Medical Communications agency, Oxford
-
Competitive Salary
- Strategic Associate Director Healthcare PR, London
-
Substantiel package
- Account Director, Healthcare Communications
-
Salary TBC
Subscribe to our email news alerts
- Communique Awards 2019: Photo Gallery - Communiqué Awards
- AbbVie’s Skyrizi gets rapid ‘yes’ from NICE
- Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms
- AbbVie’s Skyrizi gets rapid ‘yes’ from NICE
- Moving annual total (MAT)
- Amgen and Novartis abandon Alzheimer’s drug after worsening symptoms
- We are Gold! Porterhouse Medical Group is recognised as an ‘Investor in People’ at the Gold level
- Illumina sets up first ex-US accelerator site in Cambridge
- Kisqali combination follows Verzenio onto Cancer Drugs Fund
- Genentech taps into Sosei Heptares GPCR expertise with $1bn alliance
- ACPs to lead gene therapies in haemophilia market growth
- FDA starts speedy review of Novartis’ sickle cell antibody
PMHub
IGNIFI
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...
Latest intelligence
- Precision paediatrics: Treating patients with CAR-T
- Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
- What does it mean to be an agile organisation
- We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
- Battling breast cancer with precision medicine (Part 2)
- Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...
Quick links
Infographics
